Long-Term Temporal Trends in Survival Among Danish Patients with Advanced Cutaneous Melanoma: A Nationwide Follow-Up Study

References

• Arnold M, Singh D, Laversanne M, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022;158(5):495–503. doi:10.1001/jamadermatol.2022.0160
   PubMed Web of Science ®Google Scholar
• Nazzaro G, Passoni E, Pozzessere F, Maronese CA, Marzano AV. Dermoscopy use leads to earlier cutaneous melanoma diagnosis in terms of invasiveness and size? A single-center, retrospective experience. J Clin Med. 2022;11(16):4912. doi:10.3390/jcm11164912
   PubMed Web of Science ®Google Scholar
• Tryggvadottir L, Gislum M, Hakulinen T, et al. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol. 2010;49(5):665–672. doi:10.3109/02841861003702528
   PubMed Web of Science ®Google Scholar
• Tichanek F, Forsti A, Hemminki A, Hemminki O, Hemminki K. Survival in melanoma in the nordic countries into the era of targeted and immunological therapies. Eur J Cancer. 2023;186:133–141. doi:10.1016/j.ejca.2023.03.019
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Erdei E, Torres SM. A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther. 2010;10(11):1811–1823. doi:10.1586/era.10.170
   PubMed Web of Science ®Google Scholar
• Böni R, Schuster C, Nehrhoff B, Burg G. Epidemiology of skin cancer. Neuro Endocrinol Lett. 2002;23:48–51.
   PubMed Web of Science ®Google Scholar
• McDermott D, Lebbé C, Hodi FS, et al. Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma. Cancer Treat Rev. 2014;40(9):1056–1064. doi:10.1016/j.ctrv.2014.06.012
   PubMed Web of Science ®Google Scholar
• Bay C, Kejs AM, Storm HH, Engholm G. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989–2011. Cancer Epidemiol. 2015;39(1):1–7. doi:10.1016/j.canep.2014.10.010
   PubMed Web of Science ®Google Scholar
• Crocetti E, Mallone S, Robsahm TE, et al. Survival of patients with skin melanoma in Europe increases further: results of the EUROCARE-5 study. Eur J Cancer. 2015;51(15):2179–2190. doi:10.1016/j.ejca.2015.07.039
   PubMed Web of Science ®Google Scholar
• Engeland A, Haldorsen T, Tretli S, et al. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries. APMIS Suppl. 1995;49:1–161.
   PubMedGoogle Scholar
• Padrik P, Valter A, Valter E, Baburin A, Innos K. Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study. Acta Oncol. 2017;56(1):52–58. doi:10.1080/0284186X.2016.1243804
   PubMed Web of Science ®Google Scholar
• Rockberg J, Amelio JM, Taylor A, Jorgensen L, Ragnhammar P, Hansson J. Epidemiology of cutaneous melanoma in Sweden-Stage-specific survival and rate of recurrence. Int J Cancer. 2016;139(12):2722–2729. doi:10.1002/ijc.30407
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sorensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-3
   PubMed Web of Science ®Google Scholar
• Storm HH. Completeness of cancer registration in Denmark 1943–1966 and efficacy of record linkage procedures. Int J Epidemiol. 1988;17(1):44–49. doi:10.1093/ije/17.1.44
   PubMed Web of Science ®Google Scholar
• Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish cancer Registry--history, content, quality and use. Dan Med Bull. 1997;44(5):535–539.
   PubMedGoogle Scholar
• Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–6206. doi:10.1200/JCO.2009.23.4799
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S91125
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003;56(3):221–229. doi:10.1016/s0895-4356(02)00585-1
   PubMed Web of Science ®Google Scholar
• Hunter HL, Dolan OM, McMullen E, Donnelly D, Gavin A. Incidence and survival in patients with cutaneous malignant melanoma: experience in a U.K. population, 1984–2009. Br J Dermatol. 2013;168(3):676–678. doi:10.1111/bjd.12046
   PubMed Web of Science ®Google Scholar
• Svedman FC, Pillas D, Taylor A, Kaur M, Linder R, Hansson J. Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. Clin Epidemiol. 2016;8:109–122. doi:10.2147/CLEP.S99021
   PubMed Web of Science ®Google Scholar
• Wouters MW, Michielin O, Bastiaannet E, et al. ECCO essential requirements for quality cancer care: melanoma. Crit Rev Oncol Hematol. 2018;122:164–178. doi:10.1016/j.critrevonc.2017.12.020
   PubMed Web of Science ®Google Scholar
• Ellebaek E, Svane IM, Schmidt H, et al. The Danish metastatic melanoma database (DAMMED): a nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients. Cancer Epidemiol. 2021;73:101943. doi:10.1016/j.canep.2021.101943
   PubMed Web of Science ®Google Scholar